Matthew Stanton
Stock Analyst at Jefferies
(0.07)
# 4,488
Out of 5,182 analysts
8
Total ratings
20%
Success rate
-29.16%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AZTA Azenta | Maintains: Buy | $42 → $40 | $24.24 | +65.02% | 3 | Feb 4, 2026 | |
| RGEN Repligen | Maintains: Hold | $145 → $135 | $117.43 | +14.96% | 1 | Sep 12, 2025 | |
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $10.10 | -20.79% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $0.92 | +252.34% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $20.90 | +5.26% | 1 | Apr 4, 2024 |
Azenta
Feb 4, 2026
Maintains: Buy
Price Target: $42 → $40
Current: $24.24
Upside: +65.02%
Repligen
Sep 12, 2025
Maintains: Hold
Price Target: $145 → $135
Current: $117.43
Upside: +14.96%
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $10.10
Upside: -20.79%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $0.92
Upside: +252.34%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $20.90
Upside: +5.26%